Brain sphingolipids in I cell disease (mucolipidosis II).
D000015:Abnormalities, Multiple / Q000378:metabolism*; D002518:Ceramides / Q000032:analysis; D002554:Cerebrosides / Q000032:analysis; D002675:Child, Preschool; D002849:Chromatography, Gas; D002855:Chromatography, Thin Layer; D003594:Cytoplasmic Granules; D005347:Fibroblasts; D005690:Galactose; D005732:Gangliosides / Q000032:analysis; D005947:Glucose; D006801:Humans; D007785:Lactose; D008064:Lipidoses / Q000378:metabolism*; D008059:Mucopolysaccharidosis I / Q000378:metabolism; D016532:Mucopolysaccharidosis II / Q000378:metabolism; D009438:Neuraminic Acids / Q000032:analysis; D012174:Retinitis Pigmentosa / Q000378:metabolism; D013107:Sphingolipids / Q000032:analysis*; D013109:Sphingomyelins / Q000032:analysis; D013433:Sulfoglycosphingolipids / Q000032:analysis; D013577:Syndrome
D002518:Ceramides; D002554:Cerebrosides; D005732:Gangliosides; D009438:Neuraminic Acids; D013107:Sphingolipids; D013109:Sphingomyelins; D013433:Sulfoglycosphingolipids; D005947:Glucose; D007785:Lactose; D005690:Galactose